0001415889-21-002243.txt : 20210504 0001415889-21-002243.hdr.sgml : 20210504 20210504163928 ACCESSION NUMBER: 0001415889-21-002243 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210501 FILED AS OF DATE: 20210504 DATE AS OF CHANGE: 20210504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cunningham Ann Michelle CENTRAL INDEX KEY: 0001764572 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37761 FILM NUMBER: 21889199 MAIL ADDRESS: STREET 1: 255 N CALDWELL CIRCLE CITY: DOWNINGTOWN STATE: PA ZIP: 19335 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc. CENTRAL INDEX KEY: 0001411685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205093315 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-577-3600 MAIL ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Excaliber Enterprises, Ltd. DATE OF NAME CHANGE: 20070906 4 1 form4-05042021_010553.xml X0306 4 2021-05-01 0001411685 VistaGen Therapeutics, Inc. VTGN 0001764572 Cunningham Ann Michelle C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 true true false false CHIEF COMMERCIAL OFFICER Stock Option (Right to Buy) 2.53 2021-05-01 4 A 0 300000 0 A 2031-05-01 Common Stock 300000 300000 D 25% of the stock options vest on the one-year anniversary of the grant date, with the remaining 75% vesting ratably on a monthly basis over the 36 months thereafter. Stock options were granted in connection with the Reporting Person's appointment to the Issuer's Board of Directors and pursuant to the Issuer's 2019 Omnibus Equity Incentive Plan. /s/ Jerrold D. Dotson, Attorney-in-Fact 2021-05-04